NCT07416409 2026-02-18
Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian Patients With ERBB2-Positive Breast Cancer
Deraya University
Completed
Clinical Trials
7 trialsNCT05467189 2022-07-20
Antineoplastic Drugs in Elderly Patients
Shandong University
Recruiting
NCT01332396 2017-04-26
Drug Use Investigation for TYKERB Tablet (All Case Investigation)
Novartis
Completed
NCT00898573 2015-10-02
Lapatinib Resistance in Patients With Breast Cancer
Case Comprehensive Cancer Center
Withdrawn
NCT01782651 2015-08-10
Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer Patients
GlaxoSmithKline
Completed
NCT00975988 2014-10-27
Regulatory TYKERB® Tablets PMS
GlaxoSmithKline
Completed
NCT01077648 2014-05-26
Brain Metastasis in Breast Cancer Patients
GlaxoSmithKline
Completed